Team

The people behind Mintmark.

Mintmark is in formation. The team will be listed here as it is confirmed.

Portrait of Shai Novik

Leadership

Shai Novik

Shai Novik has spent his career building, financing and selling companies in the public markets.

He is the co-founder and Executive Chairman of Enlivex Therapeutics (Nasdaq: ENLV). In 2005 he founded PROLOR Biotech, which he managed through its U.S. stock-exchange listing in 2010 and its sale in 2013 in a transaction valued at $560 million.

Earlier he was Chief Operating Officer, Head of Strategic Planning and Head of the Investment Committee at THCG, a New York technology and life-sciences venture capital firm. He holds an M.B.A. with distinction from Cornell University.

Today
Co-founder and Executive Chairman, Enlivex Therapeutics (Nasdaq: ENLV)
Before
Founder, PROLOR Biotech (2005). Listed in the U.S. in 2010, sold in 2013
Earlier
Chief Operating Officer, THCG (venture capital, New York)
Education
M.B.A. with distinction, Cornell University

Biography based on the published Enlivex Therapeutics management profile.